BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3918886)

  • 1. Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product.
    Lagarde M; Burtin M; Rigaud M; Sprecher H; Dechavanne M; Renaud S
    FEBS Lett; 1985 Feb; 181(1):53-6. PubMed ID: 3918886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of the 15-hydroxy derivative of dihomogammalinolenic acid in human platelets and its biological effect.
    Guichardant M; Naltachayan-Durbin S; Lagarde M
    Biochim Biophys Acta; 1988 Sep; 962(1):149-54. PubMed ID: 2843240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products.
    Miller CC; McCreedy CA; Jones AD; Ziboh VA
    Prostaglandins; 1988 Jun; 35(6):917-38. PubMed ID: 3141974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway.
    Jakschik BA; Morrison AR; Sprecher H
    J Biol Chem; 1983 Nov; 258(21):12797-800. PubMed ID: 6313677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and purification of soybean lipoxygenase-derived unsaturated hydroperoxy and hydroxy fatty acids and determination of molar absorptivities of hydroxy fatty acids.
    Graff G; Anderson LA; Jaques LW
    Anal Biochem; 1990 Jul; 188(1):38-47. PubMed ID: 2121063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation.
    Lagarde M; Burtin M; Sprecher H; Dechavanne M; Renaud S
    Lipids; 1983 Apr; 18(4):291-4. PubMed ID: 6408333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids.
    Guichardant M; Lagarde M
    Biochim Biophys Acta; 1985 Sep; 836(2):210-4. PubMed ID: 3927982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a new lipoxygenase metabolite of arachidonic acid, 8. 11, 12-trihydroxy-5,9,14-eicosatrienoic acid from human platelets.
    Bryant RW; Bailey JM
    Prostaglandins; 1979 Jan; 17(1):9-18. PubMed ID: 108769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets.
    Lagarde M; Drouot B; Guichardant M; Dechavanne M
    Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid-derived lipid mediators and blood platelet aggregation.
    Lagarde M; Chen P; VĂ©ricel E; Guichardant M
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):227-30. PubMed ID: 20207119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxygenase-catalyzed transformation of epoxy fatty acids to hydroxy-endoperoxides: a potential P450 and lipoxygenase interaction.
    Teder T; Boeglin WE; Brash AR
    J Lipid Res; 2014 Dec; 55(12):2587-96. PubMed ID: 25293588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells.
    Campbell WB; Falck JR; Okita JR; Johnson AR; Callahan KS
    Biochim Biophys Acta; 1985 Oct; 837(1):67-76. PubMed ID: 3931686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid.
    Lagarde M; Guichardant M; Dechavanne M
    Prog Lipid Res; 1981; 20():439-43. PubMed ID: 6804973
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the arachidonate lipoxygenase pathway in blood platelet aggregation.
    Dutilh CE; Haddeman E; ten Hoor F
    Adv Prostaglandin Thromboxane Res; 1980; 6():101-5. PubMed ID: 6770586
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system.
    Elliott WJ; Morrison AR; Sprecher H; Needleman P
    J Biol Chem; 1986 May; 261(15):6719-24. PubMed ID: 3084488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of prostaglandin synthetase substrate analogues. 2. (8Z,11Z,14Z)-15-Methyl-8,11,14-eicosatrienoic acid.
    Dawson MI; Reid M; Hemler ME; Lands WE
    J Med Chem; 1977 Nov; 20(11):1396-400. PubMed ID: 410929
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
    Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
    Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 8,11,14-icosatrienoic acid by fetal calf aorta.
    Powell WS; Funk CD
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():111-7. PubMed ID: 6221512
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of trihydroxyheptadecenoic acids, monohydroxyicosatrienoic acids, and prostaglandins from 8,11,14-icosatrienoic acid by adult and fetal aorta.
    Powell WS
    J Biol Chem; 1982 Aug; 257(16):9465-72. PubMed ID: 7202002
    [No Abstract]   [Full Text] [Related]  

  • 20. A biosynthetic pathway generating 12-hydroxy-5,8,14-eicosatrienoic acid from arachidonic acid is active in mouse skin microsomes.
    Du L; Yermalitsky V; Hachey DL; Jagadeesh SG; Falck JR; Keeney DS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):371-9. PubMed ID: 16169934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.